AI industry uncertainty and caution ahead of U.S. corporate earnings led to a foreign net sell-off of 1.38 trillion KRW on the KOSPI.
KOSDAQ slipped to the 660 range, while stocks related to AI exam cheating prevention and smart glasses surged.
On November 16, South Korean markets saw both the KOSPI and KOSDAQ indices suffer sharp declines. Persistent uncertainty surrounding the artificial intelligence (AI) industry, combined with investor caution ahead of major U.S. corporate earnings reports, triggered an expansion in foreign selling. The KOSPI fell for the third consecutive session, barely clinging to the 5100 level, while the KOSDAQ plunged nearly 5% to close in the 660 range.
According to the Korea Exchange, the KOSPI closed at 5100.50, down 190.03 points (3.59%). The KOSDAQ finished at 665.65, down 34.01 points (4.86%). The won-dollar exchange rate closed at 1335.7 won, down 1.0 won from the previous session.
The KOSPI opened higher on bargain hunting despite the weakness of major U.S. tech stocks late last week. However, the index turned downward as foreign selling intensified, particularly in the electrical and electronics sectors, driven by ongoing AI industry concerns and anticipation of U.S. earnings results.
By sector, electrical and electronics fell 5.6%, machinery and equipment dropped 4.0%, medical and precision instruments declined 3.9%, and construction fell 2.4%. Large-cap stocks fell 3.8%, mid-caps 1.0%, and small-caps 1.4%.
In terms of trading activity, foreigners and institutions net sold 1.38 trillion KRW and 459.9 billion KRW, respectively, while retail investors net bought 1.35 trillion KRW. Foreigners net sold 1.17 trillion KRW in electrical and electronics, 55.7 billion KRW in finance, and 51.3 billion KRW in transportation equipment and parts.
The KOSDAQ also opened higher but reversed course as foreign and institutional selling expanded, particularly in the electrical, electronics, and machinery sectors. Machinery and equipment fell 7.6%, non-metals 7.4%, and publishing and media 6.6%. Foreigners and institutions net sold 211.2 billion KRW and 154.1 billion KRW, respectively, while retail investors net bought 376.8 billion KRW.
AI Exam Cheating Concerns Drive Surge in Security and Smart Glasses Stocks
Despite the broader market slump, security and camera-related stocks surged as concerns over AI-assisted exam cheating spread. The Ministry of Economy and Finance announced on the 16th that it would form a task force to prevent the recurrence of cheating on tax accountant exams, fueling buying interest in related stocks.
Gisun (446840) hit the daily upper limit, rising 29.97% on expectations of benefiting from AI exam security technology. Katis (140430) also hit the daily limit, rising 29.87%, while MDS Tech (086960) rose 10.87% as its thermal imaging camera technology gained attention.
Stocks related to AI smart glasses and augmented reality (AR) also showed strength. Sekonix (056090) hit the daily limit, rising 29.83% due to its optical lens and camera technology. Namuga (190510) hit the daily limit of 30.00% on expectations regarding Samsung Electronics' AI smart glasses business, and Sapien Semiconductor (452430) rose 13.09%.
Individual Stocks Rally on Earnings and Business News
Mirae Asset Venture Investment (100790) surged 17.13% following news of SpaceX's successful recovery of its 'Starship' booster. Hanwha General Insurance (000370) rose 5.01% after reporting a 34.1% year-on-year increase in third-quarter net profit and a Supreme Court acquittal regarding insurance bid-rigging allegations.
Cj Medtech (056090) rose 8.28% after reporting a 204% increase in third-quarter operating profit to 3 billion KRW, while VT (018290) rose 8.74% with a 23% increase in operating profit to 14.9 billion KRW. Samyang Foods (003230) rose 6.20% on expectations for overseas sales growth, and P&S Robotics (460940) climbed 9.09% on rising demand for medical and welfare robots.
Conversely, HLB Therapeutics (115450) hit the daily lower limit, falling 29.98% after its 'RGN-259' candidate for neurotrophic keratitis failed to meet primary endpoints in a U.S. Phase 3 clinical trial. Genohco (361390) fell 5.66% after reporting a third-quarter operating loss of 1.1 billion KRW, and SK Eternix (475150) fell 6.21% as it swung to an operating loss of 3.7 billion KRW. Misto Holdings (086960) plunged 12.78% on declining quarterly profits.
Newly listed Youngkwang YKMC (345290) closed at 9,200 KRW, down 16.36% from its IPO price of 11,000 KRW.







